Literature DB >> 9696877

Preactivation of B lymphocytes does not enhance mouse mammary tumor virus infection.

D Finke1, L Mortezavi, H Acha-Orbea.   

Abstract

We investigated whether mouse mammary tumor virus (MMTV) favors preactivated or naive B cells as targets for efficient infection. We have demonstrated previously that MMTV activates B cells upon infection. Here, we show that polyclonal activation of B cells leads instead to lower infection levels and attenuated superantigen-specific T-cell responses in vivo. This indicates that naive small resting B cells are the major targets of MMTV infection and that the activation induced by MMTV is sufficient to allow efficient infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696877      PMCID: PMC110044     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  A change in growth potential of cells after conversion by Rous sarcoma virus.

Authors:  J P Bader
Journal:  J Cell Physiol       Date:  1967-12       Impact factor: 6.384

2.  MHC class II limits the functional expression of endogenous superantigens in B cells.

Authors:  F E Lund; T D Randall; D L Woodland; R B Corley
Journal:  J Immunol       Date:  1993-01-01       Impact factor: 5.422

3.  Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.

Authors:  W Held; G A Waanders; A N Shakhov; L Scarpellino; H Acha-Orbea; H R MacDonald
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

4.  Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication.

Authors:  W Y Gao; A Cara; R C Gallo; F Lori
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

5.  Inhibition of lipopolysaccharide-induced activation of immature B cells by anti-mu and anti-delta antibodies and its modulation by interleukin-4.

Authors:  R D Brines; G G Klaus
Journal:  Int Immunol       Date:  1992-07       Impact factor: 4.823

6.  Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes.

Authors:  J B Weinberg; T J Matthews; B R Cullen; M H Malim
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

7.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

8.  Human immunodeficiency virus infection of cells arrested in the cell cycle.

Authors:  P Lewis; M Hensel; M Emerman
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

9.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

10.  An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).

Authors:  W Held; A N Shakhov; G Waanders; L Scarpellino; R Luethy; J P Kraehenbuhl; H R MacDonald; H Acha-Orbea
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  3 in total

1.  Intercellular transfer of a soluble viral superantigen.

Authors:  M Reilly; D Mix; A A Reilly; X Y Ye; G M Winslow
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Murine retroviruses activate B cells via interaction with toll-like receptor 4.

Authors:  John C Rassa; Jennifer L Meyers; Yuanming Zhang; Rama Kudaravalli; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 3.  Intestinal Immune System and Amplification of Mouse Mammary Tumor Virus.

Authors:  Lankai Chen; Xipeng Zhang; Guisheng Liu; Shuo Chen; Minying Zheng; Siwei Zhu; Shiwu Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.